Use and interpretation of virological tests for hepatitis C. - Wikidata - wikimedia - TriplyDB

Use and interpretation of virological tests for hepatitis C.

Use and interpretation of virological tests for hepatitis C.

http://www.wikidata.org/entity/Q34984049

about

Pegylated interferon alpha 2a versus pegylated interferon alpha 2b for chronic hepatitis C Improved COBAS TaqMan Hepatitis C Virus Test (Version 2.0) for Use with the High Pure System: Enhanced Genotype Inclusivity and Performance Characteristics in a Multisite Study KASL clinical practice guidelines: management of hepatitis C Update on hepatitis B and C virus diagnosis Hepatitis C virus markers in infection by hepatitis C virus: In the era of directly acting antivirals Hepatitis C cirrhosis: New perspectives for diagnosis and treatment Dynamic range of hepatitis C virus RNA quantification with the Cobas Ampliprep-Cobas Amplicor HCV Monitor v2.0 assay.Evaluation of the COBAS Hepatitis C Virus (HCV) TaqMan Analyte-Specific Reagent Assay and Comparison to the COBAS Amplicor HCV Monitor V2.0 and Versant HCV bDNA 3.0 Assays Simultaneous Detection of Hepatitis C Virus (HCV) Core Antigen and Anti-HCV Antibodies Improves the Early Detection of HCV Infection Use of Sequence Analysis of the NS5B Region for Routine Genotyping of Hepatitis C Virus with Reference to C/E1 and 5' Untranslated Region Sequences Factors Affecting Serum Concentrations of Hepatitis C Virus (HCV) RNA in HCV Genotype 1-Infected Patients with Chronic Hepatitis Performance of the Abbott Real-Time PCR Assay Using m2000sp and m2000rt for Hepatitis C Virus RNA Quantification Prevalence and risk factors for Hepatitis C and HIV-1 infections among pregnant women in Central Brazil Pathogenesis of Hepatitis C Virus Infection in Tupaia belangeri Factors associated with seroprevalence of hepatitis C among dentists at a large Brazilian city Hepatitis C virus: Virology, diagnosis and treatment Diagnostic tests for hepatitis C: recent trends in electrochemical immunosensor and genosensor analysis.Naturally occurring mutations in the nonstructural region 5B of hepatitis C virus (HCV) from treatment-naïve Korean patients chronically infected with HCV genotype 1b.Treatment of hepatitis C. The 2002 French consensus.Improving health care and laboratory medicine: the past, present, and future of molecular diagnostics.Hepatitis C virus: virology, diagnosis and management of antiviral therapy.Hepatitis C virus serologic and virologic tests and clinical diagnosis of HCV-related liver disease A practical approach to managing patients with HCV infection.Comparison of the Mechanisms of Drug Resistance among HIV, Hepatitis B, and Hepatitis C.Development of a multiplex bead-based assay for detection of hepatitis C virus Evidence-based consensus on the diagnosis, prevention and management of hepatitis C virus disease.Multiplexed quantification of nucleic acids with large dynamic range using multivolume digital RT-PCR on a rotational SlipChip tested with HIV and hepatitis C viral load Molecular beacon probes-base multiplex NASBA Real-time for detection of HIV-1 and HCV.Multicenter evaluation of the performance characteristics of the bayer VERSANT HCV RNA 3.0 assay (bDNA)Lack of evidence of hepatitis C and HIV co-infection among men who have sex with men in Peru Prevalence of HIV and HCV infections in two populations of Malian women and serological assays performances.Evaluation of operational chronic infection endpoints for HCV vaccine trials Hepatitis C virus (HCV) core antigen assay to detect ongoing HCV infection in thai injection drug users.Significance of anti-HCV signal-to-cutoff ratio in predicting hepatitis C viremia.Hepatitis C Virus in mainland China with an emphasis on genotype and subtype distribution.Hepatitis C virus infection in Egyptian children with type 1 diabetes mellitus: A single center study.Loop-Mediated Isothermal Amplification Assay for Rapid Detection of Hepatitis C virus.Design and development of an in-house multiplex RT-PCR assay for simultaneous detection of HIV-1 and HCV in plasma samples.Comparison of serological and nucleic Acid based assays used to diagnose hepatitis C virus (HCV) infection in acute and chronic liver diseases.Mutations in the NS5A and E2-PePHD regions of hepatitis C virus genotype 1b and response to combination therapy of interferon plus ribavirin.

P2860

Q24240315-C2CD9341-2773-4DD9-8643-17D74DACD4F2 Q24289102-14595BBD-7342-4FC1-9A5C-FC145061CD04 Q26752471-26DFE3E9-2681-456E-9F60-057E0FDF8EE1 Q26777048-18F39333-43B3-417C-A5FC-72FDB0BBCD64 Q26782033-B17BE6C2-87AD-4FA9-8348-D09F7E3D75B4 Q26799924-66F7B027-A247-40BA-861A-3A7C9BC023B6 Q27469461-F818E134-4B65-4485-A374-929F4F8B366E Q27469990-CE3BFEB2-0575-4577-B433-D9B52ECD1E6E Q27471998-6F7A1C72-1CAC-4525-91B9-3F38F048114A Q27478359-36C23BE6-9FF2-49D0-A670-A440B0AFD537 Q27480999-4C5F7744-66AA-4AE8-86AF-0D696F645E6E Q27488563-EFFB28D7-B7E4-4D1C-A798-58EB2F7DC9F4 Q27489255-11CE9552-FCFF-4655-8F42-DA44761B30B7 Q27490544-29367621-66B5-47EB-9634-BEEB1B704394 Q27490798-5B005CB6-10CB-413A-859A-E6C8764A4B4F Q28082000-7CC9FA15-6D19-4F7C-8F38-104FF3AA08EA Q30426257-A58A67E2-9D4F-4E1D-8509-5BB452DE0817 Q31149778-CFCACCF3-91F3-4453-9660-6C1FF8C2E15B Q33195269-12D440C0-2BE3-4062-8E97-35045D31891C Q33945114-B3ADAAFE-0C7F-43AC-99DC-935E2366D58F Q34098547-064A11F7-DF16-4DE6-972C-85AB1F7C638E Q34485061-96814DB9-4C87-4D90-90E2-DF36A11E83F1 Q34485082-3A64DA9C-A728-46CF-8FD6-2B4E075C2545 Q34489239-43BD0ACD-0B89-4DC6-A1A7-9637239BD4BC Q35066209-FB35A947-17D5-4F78-9CC2-AA505C2EE5AD Q35237341-3F933B77-EC45-4054-B1B4-14065BACE9D3 Q35551793-5C01CC46-2E95-461D-A8C7-774BFB67F5DD Q36211386-1B72AB69-F127-4A3B-8A96-9BE6AF22BB4D Q36240147-3DF7CDCA-375B-4A9B-85E0-4E64DF4A554E Q36405745-988EDC95-D4DD-4FC7-912B-D9577F95449F Q36561576-1C568715-FA71-48CA-A9E4-25809153C786 Q36978905-31C8CAB6-6B74-4AB5-87D1-CF226FC43CDF Q37420620-C074C757-5224-49AC-B286-126294DFFEAD Q37445272-59280813-D6F8-4DAA-BFCC-BD5C85968729 Q37663438-1FCD9B9E-D1C6-452A-9A75-7C2F7AA44DD4 Q37703702-1D167A45-4605-4D5A-8250-ABF81A9D24F8 Q42109065-E5D4BF0B-8466-4F10-88E2-0EABC3DCD097 Q42228568-DFE62B7A-AA8C-4FDC-8CE4-2CB1D12483E5 Q42708052-5A6D4120-6E40-4710-961B-ABDF8B4C8F32 Q42983450-7B08A022-4E61-4278-9965-98DB633984E7

P2860

Use and interpretation of virological tests for hepatitis C.

http://www.wikidata.org/entity/Q34984049

description

2002 nî lūn-bûn

@nan

2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Use and interpretation of virological tests for hepatitis C.

@ast

Use and interpretation of virological tests for hepatitis C.

@en

Use and interpretation of virological tests for hepatitis C.

@nl

type

label

Use and interpretation of virological tests for hepatitis C.

@ast

Use and interpretation of virological tests for hepatitis C.

@en

Use and interpretation of virological tests for hepatitis C.

@nl

prefLabel

Use and interpretation of virological tests for hepatitis C.

@ast

Use and interpretation of virological tests for hepatitis C.

@en

Use and interpretation of virological tests for hepatitis C.

@nl

P1433

Q34984049-49122C74-469B-4C47-A15C-0B863ADFEF4D

P1476

Q34984049-70FDDD48-961B-43A6-891C-5A9E7A301E01

P2093

Q34984049-6DB586D0-F501-47FE-8DDC-4C07CB055741

P2860

Q34984049-03835FB9-0FA4-4EC5-8C1F-74024289836A

Q34984049-0E9BDE69-F201-4754-B77B-9C0FAE5663AF

Q34984049-297A582E-6742-47CE-AB2F-646B8480A790

Q34984049-2A4F0472-7AAC-421C-8933-FEDA6902B4E6

Q34984049-2EA0C52A-EC22-4E18-B525-16F956D37F6B

Q34984049-38D47BE7-6ED5-4B97-836F-1C0D5A1073BF

Q34984049-3A21E9EC-4650-45A9-AC7C-F62C38D733FC

Q34984049-3B0EE1D2-1F2B-44E3-9977-E283B0C401C0

Q34984049-417729A7-52C1-4C55-B369-A1FBEBABFC51

Q34984049-42358D5B-5CF6-4DD9-AFBF-CD29D9751566

P304

Q34984049-6A8BF4C7-6FCE-46B8-BAD9-B16E656E0973

P31

Q34984049-5BFD04AE-0731-4DDD-8FFE-25F2251908D2

P356

Q34984049-1408BA17-4AB1-4A6F-A42A-9984373BBF9D

P407

Q34984049-3CBC0C51-2BA2-4D28-83D7-23BC6B8C51BE

P433

Q34984049-5E766B83-E41C-44DA-BA39-AD51B596A22F

P478

Q34984049-2E25E6BB-9ED1-48C1-AFCB-D7638958414A

P50

Q34984049-385C2AD7-3FB1-449A-9723-EB69BC8C214E

P577

Q34984049-FBE65401-8B00-4E45-9CD2-93E3F24FB3CE

P5875

Q34984049-EF22AB4A-C840-44AB-9A78-DF5F4A276CD4

P698

Q34984049-94014122-822D-4687-A54D-7072E553ADDB

P921

Q34984049-802440AF-CE52-448E-BBD8-DB43BBCC0ECA

P356

JHEP.2002.36815

P1433

P1476

Use and interpretation of virological tests for hepatitis C.

@en

P2093

Jean-Michel Pawlotsky

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Nucleic acid sequence-based amplification

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

Viral heterogeneity of the hepatitis C virus.

NAT of the United States and Canadian blood supply.

Molecular diagnosis of viral hepatitis.

Efficacy of a hepatitis C virus core antigen enzyme-linked immunosorbent assay for the identification of 'window-phase' blood donations.

Measuring hepatitis C viremia in clinical samples: can we trust the assays?

P304

S65-73

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/JHEP.2002.36815

http://www.w3.org/2001/XMLSchema#string

P407

P433

5 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P50

Jean-Michel Pawlotsky

P577

2002-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11056235

http://www.w3.org/2001/XMLSchema#string

P698

12407578

http://www.w3.org/2001/XMLSchema#string

P921